United Kingdom· GB-APID-34180011000001102
Zavicefta 2g/0.5g powder for concentrate for solution for infusion vials
A medicinal product containing ceftazidime + avibactam, registered in United Kingdom by Pfizer Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Ceftazidime + Avibactam
- Manufacturer
- Pfizer Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 3
- gtin5000456013680
- gtin5013457012132
- gtin5415062371749
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ceftazidime + avibactam in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandZaviceftaPfizer Ireland Pharmaceuticals Unlimited Company
- SpainZAVICEFTA 2 G/0,5 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONPfizer Ireland Pharmaceuticals
- United StatesAVYCAZAllergan, Inc.
- IrelandZavicefta 2 g/0.5 g powder for concentrate for solution for infusionPfizer Ireland Pharmaceuticals
- SwitzerlandZavicefta, Pulver für ein Konzentrat zur Herstellung einer InfusionslösungPfizer AG
- NetherlandsZAVICEFTA 2 g/0,5 g, poeder voor concentraat voor oplossing voor infusiePfizer Ireland Pharmaceuticals, Operations Services Group
- NorwayZaviceftaPfizer Ireland Pharmaceuticals Unlimited Company
- PolandZaviceftaPfizer Ireland Pharmaceuticals
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Zavicefta
- Liechtenstein · Zavicefta
- Norway · Zavicefta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/be89a075-535e-4be8-9892-41266014c50a GET /v1/drugs/be89a075-535e-4be8-9892-41266014c50a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "34180011000001102",
"desc": "Zavicefta 2g/0.5g powder for concentrate for solution for infusion vials (Pfizer Ltd)",
"form": "Powder for solution for infusion",
"vpid": "34179911000001103",
"source": "dmd",
"vtm_id": "781300005",
"strength": "2 gram",
"substance": "Ceftazidime + Avibactam",
"ingredient": "Ceftazidime pentahydrate",
"supplier_code": "2082201000001106"
}See everything about ceftazidime + avibactam.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.